Comparative analysis on risk assessment methods of small and medium-sized enterprises

2015 ◽  
pp. 889-894
Keyword(s):  
Risk Assessment ◽  
Comparative Analysis ◽  
Assessment Methods

scholarly journals Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sanghee Lee ◽  
Yoon Jung Chang ◽  
Hyunsoon Cho
Keyword(s):  
Risk Assessment ◽  
Health Insurance ◽  
Cancer Patients ◽  
National Health Insurance ◽  
National Health ◽  
Cancer Mortality ◽  
Prediction Models ◽  
Assessment Methods ◽  
Chronic Obstructive ◽  
Mortality Risks

Abstract Background Cancer patients’ prognoses are complicated by comorbidities. Prognostic prediction models with inappropriate comorbidity adjustments yield biased survival estimates. However, an appropriate claims-based comorbidity risk assessment method remains unclear. This study aimed to compare methods used to capture comorbidities from claims data and predict non-cancer mortality risks among cancer patients. Methods Data were obtained from the National Health Insurance Service-National Sample Cohort database in Korea; 2979 cancer patients diagnosed in 2006 were considered. Claims-based Charlson Comorbidity Index was evaluated according to the various assessment methods: different periods in washout window, lookback, and claim types. The prevalence of comorbidities and associated non-cancer mortality risks were compared. The Cox proportional hazards models considering left-truncation were used to estimate the non-cancer mortality risks. Results The prevalence of peptic ulcer, the most common comorbidity, ranged from 1.5 to 31.0%, and the proportion of patients with ≥1 comorbidity ranged from 4.5 to 58.4%, depending on the assessment methods. Outpatient claims captured 96.9% of patients with chronic obstructive pulmonary disease; however, they captured only 65.2% of patients with myocardial infarction. The different assessment methods affected non-cancer mortality risks; for example, the hazard ratios for patients with moderate comorbidity (CCI 3–4) varied from 1.0 (95% CI: 0.6–1.6) to 5.0 (95% CI: 2.7–9.3). Inpatient claims resulted in relatively higher estimates reflective of disease severity. Conclusions The prevalence of comorbidities and associated non-cancer mortality risks varied considerably by the assessment methods. Researchers should understand the complexity of comorbidity assessments in claims-based risk assessment and select an optimal approach.

Geomorphosites Assessment Methods: Comparative Analysis and Typology

Geoheritage ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 1799-1815 ◽  
Author(s):  
Vanessa Costa Mucivuna ◽  
Emmanuel Reynard ◽  
Maria da Glória Motta Garcia
Keyword(s):  
Comparative Analysis ◽  
Assessment Methods

Risk assessment of waterborne protozoa: current status and future trends

Parasitology ◽  
1999 ◽  
Vol 117 (7) ◽  
pp. 205-212 ◽  
Author(s):  
C. J. GIBSON ◽  
C. N. HAAS ◽  
J. B. ROSE
Keyword(s):  
Risk Assessment ◽  
Management Practices ◽  
Assessment Methods ◽  
Detection Methods ◽  
Current Status ◽  
Future Research ◽  
Microbial Risk Assessment ◽  
Microbial Risk ◽  
Chemical Risk Assessment ◽  
Low Levels

Throughout the past decade much research has been directed towards identifying the occurrence, epidemiology, and risks associated with waterborne protozoa. While outbreaks are continually documented, sporadic cases of disease associated with exposure to low levels of waterborne protozoa are of increasing concern. Current methodologies may not be sensitive enough to define these low levels of disease. However, risk assessment methods may be utilised to address these low level contamination events. The purpose of this article is to provide an introduction to microbial risk assessment for waterborne protozoa. Risk assessment is a useful tool for evaluating relative risks and can be used for development of policies to decrease risks. Numerous studies have been published on risk assessment methods for pathogenic protozoa including Cryptosporidium and Giardia. One common notion prevails: microbial risk assessment presents interesting complications to the traditional chemical risk assessment paradigm. Single microbial exposures (non-threshold) are capable of causing symptomatic illness unlike traditional chemical exposures, which require a threshold to be reached. Due to the lack of efficient recovery and detection methods for protozoa, we may be underestimating the occurrence, concentration and distribution of these pathogenic micro-organisms. To better utilize the tool of microbial risk assessment for risk management practices, future research should focus in the area of exposure assessment.

ASPECTS OF INDUSTRIAL CPS CRITICAL FOR RISK ASSESSMENT METHODS

2021 ◽  
Vol 3 (3) ◽  
pp. 23-29
Author(s):  
Tagir Fabarisov ◽  
Georg Siedel ◽  
Silvia Vock ◽  
Andrey Morozov
Keyword(s):  
Risk Assessment ◽  
Assessment Methods
Sign in / Sign up

Export Citation Format

Share Document